Gyre Therapeutics, Inc. Increase (Decrease) in Deferred Revenue
Gyre Therapeutics, Inc. (GYRE) reported Increase (Decrease) in Deferred Revenue of -$8.21 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-08-07
- Gyre Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2018-03-31 was -$6.00K.
- Gyre Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was -$318.00K.
- Gyre Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2017-09-30 was -$318.00K.
- Gyre Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2017-06-30 was $589.00K.
- Gyre Therapeutics, Inc. increase (decrease) in deferred revenue for fiscal 2017 was -$118.00K.
- Gyre Therapeutics, Inc. increase (decrease) in deferred revenue for fiscal 2016 was -$400.00K.
- Gyre Therapeutics, Inc. increase (decrease) in deferred revenue for fiscal 2015 was -$1.75M.
- Gyre Therapeutics, Inc. increase (decrease) in deferred revenue for fiscal 2014 was -$313.00K, a 111.21% decline from fiscal 2013.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 6 month as first filed | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 9 month as first filed | Increase (Decrease) in Deferred Revenue 12 month | Increase (Decrease) in Deferred Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-06-30 | -$8.21M 10-Q · filed 2026-08-07 | ||||||
| 2018-03-31 | -$6.00K 10-Q · filed 2018-05-03 | -$324.00K derived: sum of 2 quarters · filed 2018-05-03 | -$642.00K derived: sum of 3 quarters · filed 2018-05-03 | -$53.00K derived: sum of 4 quarters · filed 2018-05-03 | |||
| 2017-12-31 | -$318.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | -$636.00K derived: sum of 2 quarters · filed 2018-03-19 | -$47.00K derived: sum of 3 quarters · filed 2018-03-19 | -$118.00K 10-K · filed 2018-03-19 | |||
| 2017-09-30 | -$318.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $271.00K derived: sum of 2 quarters · filed 2017-11-02 | $200.00K 10-Q · filed 2017-11-02 | $129.00K derived: sum of 4 quarters · filed 2018-05-03 | |||
| 2017-06-30 | $589.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $518.00K 10-Q · filed 2017-08-03 | $447.00K derived: sum of 3 quarters · filed 2018-05-03 | $338.00K derived: sum of 4 quarters · filed 2018-05-03 | |||
| 2017-03-31 | -$71.00K 10-Q · filed 2018-05-03 | -$142.00K derived: sum of 2 quarters · filed 2018-05-03 | -$251.00K derived: sum of 3 quarters · filed 2018-05-03 | -$362.00K derived: sum of 4 quarters · filed 2018-05-03 | |||
| 2016-12-31 | -$71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | -$180.00K derived: sum of 2 quarters · filed 2018-03-19 | -$291.00K derived: sum of 3 quarters · filed 2018-03-19 | -$400.00K 10-K · filed 2018-03-19 | |||
| 2016-09-30 | -$109.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$220.00K derived: sum of 2 quarters · filed 2017-11-02 | -$329.00K 10-Q · filed 2017-11-02 | -$438.00K derived: sum of 4 quarters · filed 2017-11-02 | |||
| 2016-06-30 | -$111.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$220.00K 10-Q · filed 2017-08-03 | -$329.00K derived: sum of 3 quarters · filed 2017-08-03 | -$438.00K derived: sum of 4 quarters · filed 2017-08-03 | |||
| 2016-03-31 | -$109.00K 10-Q · filed 2017-05-11 | -$218.00K derived: sum of 2 quarters · filed 2017-05-11 | -$327.00K derived: sum of 3 quarters · filed 2017-05-11 | -$1.19M derived: sum of 4 quarters · filed 2017-05-11 | |||
| 2015-12-31 | -$109.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | -$218.00K derived: sum of 2 quarters · filed 2017-03-08 | -$1.08M derived: sum of 3 quarters · filed 2017-03-08 | -$1.75M 10-K · filed 2017-03-08 | |||
| 2015-09-30 | -$109.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$968.00K derived: sum of 2 quarters · filed 2016-11-03 | -$1.64M 10-Q · filed 2016-11-03 | -$2.31M derived: sum of 4 quarters · filed 2016-11-03 | |||
| 2015-06-30 | -$859.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$1.53M 10-Q · filed 2016-08-04 | -$2.20M derived: sum of 3 quarters · filed 2016-08-04 | -$1.25M derived: sum of 4 quarters · filed 2016-08-04 | |||
| 2015-03-31 | -$672.00K 10-Q · filed 2016-05-05 | -$1.34M derived: sum of 2 quarters · filed 2016-05-05 | -$391.00K derived: sum of 3 quarters · filed 2016-05-05 | -$1.13M derived: sum of 4 quarters · filed 2016-05-05 | |||
| 2014-12-31 | -$672.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | $281.00K derived: sum of 2 quarters · filed 2016-03-09 | -$461.00K derived: sum of 3 quarters · filed 2016-03-09 | -$313.00K 10-K · filed 2016-03-09 | $148.00K 10-K · filed 2015-03-16 | ||
| 2014-09-30 | $953.00K derived: 10-Q 9 month − 8-K/A 6 month · filed 2015-11-05 | $211.00K derived: sum of 2 quarters · filed 2015-11-05 | $359.00K 10-Q · filed 2015-11-05 | $148.00K 10-Q · filed 2014-11-06 | |||
| 2014-06-30 | -$742.00K derived: 8-K/A 6 month − 10-Q 3 month · filed 2015-10-23 | -$594.00K 8-K/A · filed 2015-10-23 | $148.00K 10-Q · filed 2014-08-07 | ||||
| 2014-03-31 | $148.00K 10-Q · filed 2015-05-07 | ||||||
| 2013-12-31 | $2.79M 10-K · filed 2016-03-09 | $2.79M 8-K/A · filed 2015-10-23 | |||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $0.00 derived: sum of 2 quarters · filed 2015-03-16 | $190.00K derived: sum of 3 quarters · filed 2015-03-16 | $440.00K 10-K · filed 2015-03-16 | |||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $190.00K derived: sum of 2 quarters · filed 2013-11-06 | $440.00K 10-Q · filed 2013-11-06 | $3.94M derived: sum of 4 quarters · filed 2014-03-14 | |||
| 2012-06-30 | $190.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $440.00K 10-Q · filed 2013-08-07 | $3.94M derived: sum of 3 quarters · filed 2014-03-14 | $6.19M derived: sum of 4 quarters · filed 2014-03-14 | |||
| 2012-03-31 | $250.00K 10-Q · filed 2013-05-08 | $3.75M derived: sum of 2 quarters · filed 2014-03-14 | $6.00M derived: sum of 3 quarters · filed 2014-03-14 | ||||
| 2011-12-31 | $3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $5.75M derived: sum of 2 quarters · filed 2014-03-14 | $5.75M 10-K · filed 2014-03-14 | ||||
| 2011-09-30 | $2.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $2.25M 10-Q · filed 2012-11-08 | |||||
| 2011-06-30 | $0.00 10-Q · filed 2011-08-09 | ||||||
| 2010-12-31 | $76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $652.00K derived: sum of 2 quarters · filed 2013-03-15 | $11.97M 10-K · filed 2013-03-15 | ||||
| 2010-09-30 | $576.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $11.90M 10-Q · filed 2011-11-03 | |||||
| 2010-06-30 | $11.32M 10-Q · filed 2011-08-09 | ||||||
| 2009-12-31 | $473.00K 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |